Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis

Abstract Background Chronic hepatitis C (HCV) infection is a leading cause of liver cirrhosis (LC) worldwide with decompensation-related clinical sequelae. Sarcopenia is currently recognized as a fundamental complication of LC owing to various mechanisms. This study aimed to assess the role of anthr...

Full description

Bibliographic Details
Main Authors: Amany Nabil Abbasy, Hoda Mohamed Abdel-Naby, Walid Ismail Ellakany
Format: Article
Language:English
Published: SpringerOpen 2023-06-01
Series:Egyptian Liver Journal
Subjects:
Online Access:https://doi.org/10.1186/s43066-023-00265-9
_version_ 1797795863059234816
author Amany Nabil Abbasy
Hoda Mohamed Abdel-Naby
Walid Ismail Ellakany
author_facet Amany Nabil Abbasy
Hoda Mohamed Abdel-Naby
Walid Ismail Ellakany
author_sort Amany Nabil Abbasy
collection DOAJ
description Abstract Background Chronic hepatitis C (HCV) infection is a leading cause of liver cirrhosis (LC) worldwide with decompensation-related clinical sequelae. Sarcopenia is currently recognized as a fundamental complication of LC owing to various mechanisms. This study aimed to assess the role of anthropometric measures of sarcopenia in predicting the outcome of LC as assessed by the Child-Turcotte-Pugh (CTP) grade. Results A cross-sectional study was carried out on 80 patients with HCV-related LC with different CTP grades. The diagnosis of sarcopenia was based on the 2018 definition of sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP). Muscle strength was assessed by hand grip strength (HGS) and lower leg extension strength (LES). Assessment of muscle mass was performed by measuring mid-calf circumference (MCC) and mid-arm muscle circumference (MAMC). HGS varied significantly between the different CTP grades, being highest in CTP grade C. Additionally, the number of patients diagnosed with “definitive sarcopenia” using either HGS/MCC or LES/MCC varied significantly between CTP grades, being highest in CTP grade C. Conclusions HGS is a better predictor of worse outcomes of liver cirrhosis than LES. The combination of MCC and HGS or LES is a potentially promising noninvasive prognostic biomarker of liver disease.
first_indexed 2024-03-13T03:24:25Z
format Article
id doaj.art-9c2745f55f03487a8ffbabd78630ac41
institution Directory Open Access Journal
issn 2090-6226
language English
last_indexed 2024-03-13T03:24:25Z
publishDate 2023-06-01
publisher SpringerOpen
record_format Article
series Egyptian Liver Journal
spelling doaj.art-9c2745f55f03487a8ffbabd78630ac412023-06-25T11:09:29ZengSpringerOpenEgyptian Liver Journal2090-62262023-06-011311910.1186/s43066-023-00265-9Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosisAmany Nabil Abbasy0Hoda Mohamed Abdel-Naby1Walid Ismail Ellakany2Department of Tropical Medicine, Faculty of Medicine, Alexandria UniversityDepartment of Physical Medicine, Faculty of Medicine, Rheumatology, and Rehabilitation, Alexandria UniversityDepartment of Tropical Medicine, Faculty of Medicine, Alexandria UniversityAbstract Background Chronic hepatitis C (HCV) infection is a leading cause of liver cirrhosis (LC) worldwide with decompensation-related clinical sequelae. Sarcopenia is currently recognized as a fundamental complication of LC owing to various mechanisms. This study aimed to assess the role of anthropometric measures of sarcopenia in predicting the outcome of LC as assessed by the Child-Turcotte-Pugh (CTP) grade. Results A cross-sectional study was carried out on 80 patients with HCV-related LC with different CTP grades. The diagnosis of sarcopenia was based on the 2018 definition of sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP). Muscle strength was assessed by hand grip strength (HGS) and lower leg extension strength (LES). Assessment of muscle mass was performed by measuring mid-calf circumference (MCC) and mid-arm muscle circumference (MAMC). HGS varied significantly between the different CTP grades, being highest in CTP grade C. Additionally, the number of patients diagnosed with “definitive sarcopenia” using either HGS/MCC or LES/MCC varied significantly between CTP grades, being highest in CTP grade C. Conclusions HGS is a better predictor of worse outcomes of liver cirrhosis than LES. The combination of MCC and HGS or LES is a potentially promising noninvasive prognostic biomarker of liver disease.https://doi.org/10.1186/s43066-023-00265-9SarcopeniaAnthropometryHCVLiver cirrhosisPrognosisOutcome
spellingShingle Amany Nabil Abbasy
Hoda Mohamed Abdel-Naby
Walid Ismail Ellakany
Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
Egyptian Liver Journal
Sarcopenia
Anthropometry
HCV
Liver cirrhosis
Prognosis
Outcome
title Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
title_full Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
title_fullStr Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
title_full_unstemmed Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
title_short Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
title_sort prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of egyptian patients with hepatitis c induced liver cirrhosis
topic Sarcopenia
Anthropometry
HCV
Liver cirrhosis
Prognosis
Outcome
url https://doi.org/10.1186/s43066-023-00265-9
work_keys_str_mv AT amanynabilabbasy prognosticanddiagnosticanthropometricbiomarkersofsarcopeniainacohortofegyptianpatientswithhepatitiscinducedlivercirrhosis
AT hodamohamedabdelnaby prognosticanddiagnosticanthropometricbiomarkersofsarcopeniainacohortofegyptianpatientswithhepatitiscinducedlivercirrhosis
AT walidismailellakany prognosticanddiagnosticanthropometricbiomarkersofsarcopeniainacohortofegyptianpatientswithhepatitiscinducedlivercirrhosis